Selected Publications
Reza Zonozi, MD, Faten Aqeel, MD, Dustin Le, MD, Frank B. Cortazar, MD, Jugal, Thaker, MD, Maria Jose Zabala Ramirez, MD, Sebastian Eduardo Sattui Cortes, MD, Rose Mary Attieh, MD, Madeline Chung, MD, David H. Bulbin, DO, Aisha Shaikh, MD, Karina Guaman, BA, Julia Ford, MD, Colin Diffie, MD, Ora Gewurz-Singer, MD, Gabriel Sauvage, BS, Anushya Jeyabalan, MD, Abdallah Geara, MD, Isabelle Ayoub, MD, Andrew Bomback, MD, Lara L. Khoury, MD, Jason C. George, DO, Kenar D., Jhaveri, MD, Vimal Kumar Derebail, MD, John L. Niles, MD, Duvuru Geetha, MD: "Real-world experience with avacopan in ANCA-associated vasculitis" Kidney International Reports : 2024.
Michelle N Rheault 1, Charles E Alpers 1, Jonathan Barratt 1, Stewart Bieler 1, Pietro Canetta 1, Dong-Wan Chae 1, Gaia Coppock 1, Ulysses Diva 1, Loreto Gesualdo 1, Hiddo J L Heerspink 1, Jula K Inrig 1, Gianna M Kirsztajn 1, Donald Kohan 1, Radko Komers 1, Laura A Kooienga 1, Kenneth Lieberman 1, Alex Mercer 1, Irene L Noronha 1, Vlado Perkovic 1, Jai Radhakrishnan 1, William Rote 1, Brad Rovin 1, Vladimir Tesar 1, Hernán Trimarchi 1, James Tumlin 1, Muh Geot Wong 1, Howard Trachtman 1; DUPRO Steering Committee and DUPLEX Investigators: "Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis" NEJM : 2023.
Rovin, B, et al: "Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial" Lancet : 2023.
Hiddo J L Heerspink 1, Jai Radhakrishnan 2, Charles E Alpers 3, Jonathan Barratt 4, Stewart Bieler 5, Ulysses Diva 6, Jula Inrig 6, Radko Komers 6, Alex Mercer 7, Irene L Noronha 8, Michelle N Rheault 9, William Rote 6, Brad Rovin 10, Howard Trachtman 11, Hernán Trimarchi 12, Muh Geot Wong 13, Vlado Perkovic 14; PROTECT Investigators: "Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial" Lancet : 2023.
Vinay Srinivasan, Bader Kfoury, Sarah Ahmad, Jordana Cohen, and Abdallah S Geara: Long term outcomes of bevacizumab-associated kidney adverse effects Journal of Onco-Nephrology : 2022.
Amudala NA, Boukhlal S, Sheridan B, Langford CA, Geara A, Merkel PA, Cornec D.: "Obinutuzumab as Treatment for ANCA-Associated Vasculitis" Rheumatology (Oxford). : 2021.
Srinivasan V, Geara AS, Han S, Hogan JJ, Coppock G.: "Need for symptom monitoring in IgA nephropathy patients post COVID-19 vaccination" Clin Nephrol : 2021.
Liann Abu Salman, Christos Kallis, Matthew Palmer, Jehan Bahrainwala, Abdallah S Geara: "New-Onset Proteinuria in a Patient With Schwannoma" American Journal Of Kidney Disease : 2021.
Shahrzad Zonoozi, Matthew Palmer, Teitelbaum Ursina, Abdallah Geara: "Worsening membranous nephropathy in a patient with GIST treated with sunitinib" BMJ Case Rep 14 (8): 2021.
Triebwasser MP, Barrett DM, Bassiri H, Bunin N, Elgarten C, Freedman J, Geara AS, Monos D, Lambert MP, Olson T, Seif AE, Paessler M, Petrosa W, Reilly AF, Romberg N, Sullivan KE, Quinn GZ, Behrens E, Teachey DT.: Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective Pediatric and Blood Cancer : 2021.
Academic Contact Information
Renal, Electrolyte and Hypertension Division
The Hospital of the University of Pennsylvania, 1 Founders Pavilion
3400 spruce street
Philadelphia,
PA
19104
Phone: 215-662-2638
Patient appointments: 800-789-7366